2013 – 2014 – Past Events

American Academy of Ophthalmology (AAO) Meeting 2012
Integrin Peptide Therapy: The Latest Human Clinical Update

Presented by Barry Kuppermann, MD PhD
November 12, 2012

45th Annual Retina Society Meeting 2012
Integrin Peptide Therapy: The First Human Diabetic Macular Edema (DME) Experience in a Phase 1 Trial

October 7, 2012
Washington, DC

30th Annual American Society of Retina Specialists (ASRS) Meeting 2012
Integrin Peptide Therapy: The Human Experience in DME

Presented by Dr. Hugo Quiroz-Mercado, MD
August 27, 2012
Las Vegas, Nevada

Club Jules Gonin 2012
Integrin Peptide Therapy: A New Class of Treatment for Vascular Eye Diseases – The First Human Experience in DME

Presented by Hugo Quiroz-Mercado, MD
June 20-12, 2012

Association for Research in Vision and Ophthalmology (ARVO) Meeting 2012
Diabetic Retinopathy- Clinical Research II

Presented by David Boyer, MD
May 6-10, 2012

World Ophthalmology Congress 2012
Integrin Inhibition as an Antiangiogenic Strategy for the Treatment of Posterior Segment

Presented by Baruch Kuppermann, MD, PhD
February 19, 2012

ISOPT Clinical 2011:
Integrin Inhibition for DME

Presented by Baruch Kuppermann, MD, PhD
December 1-4, 2011

American Academy of Ophthalmology Conference, Retina Subspecialty Day 2011
Integrin Peptide Therapy As The Next Generation Treatment for Vascular Eye Diseases

Presented by Hugo Quiroz-Mercado, MD
October 21, 2011

The Retina Society Annual Scientific Meeting 2011
Phase I Human Safety Study of Integrin Antagonist in Diabetic Retinopathy Subjects

Presented by Hugo Quiroz-Mercado, MD
September 22, 2011